Ceftobiprole vs. Daptomycin: A Treatment Study for Staphylococcus Aureus Bacteremia
Ceftobiprole for Treatment of Complicated Staphylococcus aureus Bacteremia A phase 3 clinical trial compared two antibiotics, ceftobiprole and daptomycin, as treatments for complicated Staphylococcus aureus bacteremia. Patients were randomly assigned to receive either ceftobiprole or daptomycin, and the primary outcome measured success in treatment after 70 days. Both antibiotics showed similar results in terms of overall treatment…
